Clinical utility of telomeres as diagnostic and short-term prognostic markers in loco-regional treatment of hepatocellular carcinoma

Table 1 Correlation between telomere length (× 10³) according to demographic characteristics and tumor size in the hepatocellular carcinoma and chronic liver disease groups

Telomere length with variables		HCC group	CLD group
Sex	Male	1.2 (1.0-1.8)	1.4 (1.1-2.2)
	Female	1.9 (1.5-2.1)	1.2 (1.0-1.5)
	P value	0.120	0.391
Smoking	Yes	1.2 (0.9-1.8)	1.4 (1.0-1.8)
	No	1.3 (1.0-2.1)	1.2 (1.1-1.9)
	P value	0.378	1.000
Hypertension	Yes	1.3 (0.9-1.8)	1.3 (0.8-1.6)
	No	1.3 (1.0-1.8)	1.4 (1.1-1.9)
	P value	0.851	0.568
Diabetes mellitus	Yes	1.1 (0.9-1.5)	1.2 (0.9-1.5)
	No	1.5 (1.2-2.1)	1.5 (1.1-2.2)
	P value	0.061	0.128
Size	≥ 5 cm	1.1 (1.0-1.5)
	< 5 cm	1.9 (1.3-2.2)
	P value	0.030a
BCLC staging	0	1.7 (1.1-2.0)
	A	2.1 (1.3-2.3)
	B	1.1 (1.0-1.5)
	P value	0.075

^aP value < 0.05.

HCC: Hepatocellular carcinoma; CLD: Chronic liver disease; BCLC: Barcelona Clinic Liver Cancer.